Zhejiang Starry Pharmaceutical Co., Ltd. Class ASSE: 603520

Announcement on Convening Performance and Cash Dividend Meeting for 2025 and Q1 2026

· Issued by Zhejiang Starry Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening Performance and Cash Dividend Meeting for 2025 and Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis

Earlier from Zhejiang Starry Pharmaceutical Co., Ltd. Class A

All Zhejiang Starry Pharmaceutical Co., Ltd. Class A news releases